AWM
PPH icon

Activest Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Activest Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.09K Hold
74
– – ﹤0.01% 623
2026
Q1 		$7.69K Hold
74
– – ﹤0.01% 740
2025
Q4 		$7.63K Hold
74
– – ﹤0.01% 711
2025
Q3 		$6.69K Hold
74
– – ﹤0.01% 590
2025
Q2 		$6.51K Hold
74
– – ﹤0.01% 511
2025
Q1 		$6.74K Sell
74
-299
-80% -$26.9K ﹤0.01% 466
2024
Q4 		$32.2K Buy
+373
New +$33.7K 0.01% 211
2023
Q1 		– Sell
-880
Closed -$70.1K – 495
2022
Q4 		$70.1K Buy
+880
New +$64.9K 0.02% 163

Other funds holding PPH

AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
RBC
Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
CWRP
Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AWA
ARQ Wealth Advisors Scottsdale, Arizona $807M AUM 19.58% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

Activest Wealth Management's PPH Position: Q2 2026 in Review

Activest Wealth Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 74 shares worth $8.09K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

Activest Wealth Management first reported a position in PPH in Q4 2022 and has held it in 8 quarters since. The position peaked at $70.1K in Q4 2022. 41 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Activest Wealth Management held 74 shares of VanEck Pharmaceutical ETF worth $8.09K as of Q2 2026.
  • Activest Wealth Management left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #623 holding.
  • Activest Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 8 quarters since.
  • Activest Wealth Management's VanEck Pharmaceutical ETF position peaked at $70.1K in Q4 2022.
  • 41 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.